Orion Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$5.29K 450
2024
Q1
$5.29K Hold
500
﹤0.01% 417
2023
Q4
$6K Hold
500
﹤0.01% 410
2023
Q3
$3.5K Buy
+500
New +$4.62K ﹤0.01% 431
2023
Q2
Sell
-500
Closed -$4.57K 194
2023
Q1
$4.57K Hold
500
﹤0.01% 406
2022
Q4
$5.71K Hold
500
﹤0.01% 337
2022
Q3
$9K Hold
500
0.01% 320
2022
Q2
$11K Hold
500
0.01% 311
2022
Q1
$18K Hold
500
0.01% 283
2021
Q4
$23K Hold
500
0.01% 243
2021
Q3
$32K Hold
500
0.02% 219
2021
Q2
$46K Sell
500
-100
-17% -$7.95K 0.03% 181
2021
Q1
$41K Sell
600
-100
-14% -$7.76K 0.03% 176
2020
Q4
$51K Buy
+700
New +$40.6K 0.04% 154

Other funds holding CDNA

Orion Capital Management's CDNA Position: Q2 2024 in Review

Orion Capital Management sold out of CareDx (CDNA) in Q2 2024, closing a stake of 500 shares — an estimated $5.29K sold.

Orion Capital Management first reported a position in CDNA in Q4 2020 and held it in 13 quarters. The position peaked at $51K in Q4 2020. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2024.

  • Orion Capital Management reported no remaining CareDx position as of Q2 2024 after selling out during the quarter.
  • Orion Capital Management sold 500 CareDx shares in Q2 2024, an estimated $5.29K.
  • Orion Capital Management first reported a position in CareDx in Q4 2020 and held it in 13 quarters.
  • Orion Capital Management's CareDx position peaked at $51K in Q4 2020.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2024.

Based on Orion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.